EDWARDS LIFESCIENCES CORPORATION vs KONINKLIJKE PHILIPS NV, two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EW and PHG diverge most: on fcf yield, EW reads 2.2% and PHG reads -1.2%; on debt / equity, EW reads 0.06 and PHG reads 0.00. The rest of the comparable metrics sit closer together. What EW's price implies is a somewhat stretched bet versus history (whole-company basis). What PHG's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EW | PHG |
|---|---|---|
| Price | $86.03 | $26.30 |
| Market cap | $50.0B | $24.9B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Mature |
| Implied growth (priced in) | — | +8.9% |
| P/E | 45.8 | 25.7 |
| P/B | 4.84 | 2.09 |
| P/S | 7.93 | 1.29 |
| EV/EBITDA | 34.7 | 7.9 |
| Revenue growth | +14.1% | +1.0% |
| Gross margin | 78.0% | 45.2% |
| Operating margin | 29.0% | 8.0% |
| Net margin | 17.4% | 5.0% |
| Return on equity | 10.6% | 8.2% |
| Return on assets | 8.2% | 3.3% |
| Return on invested capital | 10.2% | 9.9% |
| FCF yield | 2.2% | -1.2% |
| Debt / equity | 0.06 | 0.00 |
| Current ratio | 4.42 | 1.32 |
| Altman Z (solvency) | 8.56 | 1.81 |
| Piotroski F (quality) | 5 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.